Mitsumasa Kurita

Title: Mitsumasa Kurita: Innovator in Parkinson's Disease Treatment

Introduction

Mitsumasa Kurita is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of Parkinson's disease. With a total of 3 patents, his work focuses on developing therapeutic drugs that address motor complications associated with this condition.

Latest Patents

Kurita's latest patents include a therapeutic drug for motor complications in Parkinson's disease. This innovative drug aims to treat motor fluctuations, such as wearing-off symptoms, by utilizing tandospirone or its pharmaceutically acceptable salts. The method involves parenteral administration to effectively manage these complications. Another significant patent addresses levodopa-induced dyskinesia in Parkinson's disease. This therapeutic drug also employs tandospirone or its derivatives to improve, delay progression, or prevent motor complications related to levodopa therapy.

Career Highlights

Throughout his career, Kurita has worked with prominent companies in the pharmaceutical industry, including Sumitomo Pharma Co., Ltd. and Sumitomo Dainippon Pharma Co., Ltd. His experience in these organizations has contributed to his expertise in developing effective treatments for neurological disorders.

Collaborations

Kurita has collaborated with notable colleagues such as Yuki Ikeda and Mitsuhiro Nakato. These partnerships have likely enhanced his research and development efforts in the field of Parkinson's disease treatment.

Conclusion

Mitsumasa Kurita's innovative work in developing therapeutic drugs for Parkinson's disease showcases his commitment to improving patient outcomes. His contributions to the medical field are invaluable and highlight the importance of continued research in this area.